BioSig Technologies Files 8-K Current Report
Ticker: STEX · Form: 8-K · Filed: Oct 22, 2024 · CIK: 1530766
| Field | Detail |
|---|---|
| Company | Biosig Technologies, Inc. (STEX) |
| Form Type | 8-K |
| Filed Date | Oct 22, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001, $35 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, current-report
TL;DR
BioSig filed an 8-K for an 'Other Event' on Oct 18th. Details TBD.
AI Summary
On October 18, 2024, BioSig Technologies, Inc. filed an 8-K report detailing an 'Other Event'. The filing does not specify the exact nature of the event but indicates it is a current report filed under the Securities Exchange Act of 1934. The company is incorporated in Delaware and its principal executive offices are located in Los Angeles, California.
Why It Matters
This filing signifies a material event has occurred for BioSig Technologies, Inc. that requires public disclosure, though the specific details are not yet elaborated in this initial report.
Risk Assessment
Risk Level: low — The filing is a standard 8-K current report and does not contain specific financial or operational details that would immediately indicate high risk.
Key Numbers
- 001-38659 — Commission File Number (Identifier for the company's SEC filings)
- 26-4333375 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- BioSig Technologies, Inc. (company) — Registrant
- October 18, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Los Angeles, California (location) — Address of principal executive offices
FAQ
What specific 'Other Event' is BioSig Technologies, Inc. reporting in this 8-K filing?
The provided text of the 8-K filing does not specify the exact nature of the 'Other Event'.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on October 18, 2024.
In which state is BioSig Technologies, Inc. incorporated?
BioSig Technologies, Inc. is incorporated in Delaware.
What is the address of BioSig Technologies, Inc.'s principal executive offices?
The principal executive offices are located at 12424 Wilshire Blvd, Suite 745, Los Angeles, California, 90025.
What is the Commission File Number for BioSig Technologies, Inc.?
The Commission File Number is 001-38659.
Filing Stats: 441 words · 2 min read · ~1 pages · Grade level 12.9 · Accepted 2024-10-22 09:00:34
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share BSGM The NASDAQ Capital M
- $35 million — value of listed securities of at least $35 million. On October 21, 2024, the Company was
Filing Documents
- form8-k.htm (8-K) — 37KB
- 0001493152-24-041894.txt ( ) — 207KB
- bsgm-20241018.xsd (EX-101.SCH) — 3KB
- bsgm-20241018_lab.xml (EX-101.LAB) — 33KB
- bsgm-20241018_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOSIG TECHNOLOGIES, INC. Date: October 22, 2024 By: /s/ Anthony Amato Name: Anthony Amato Title: Chief Executive Officer